Slán Medicinal Holdings (Cosyntropin Depot) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Slán Medicinal Holdings (Cosyntropin Depot) General Information

Description

A synthetic corticotropin. The asset stimulates the adrenal gland to release two hormones: cortisol and adrenaline (epinephrine).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Ireland
Primary Industry
Buildings and Property
Corporate Office
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Slán Medicinal Holdings (Cosyntropin Depot) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Slán Medicinal Holdings (Cosyntropin Depot)‘s full profile, request access.

Request a free trial

Slán Medicinal Holdings (Cosyntropin Depot) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Slán Medicinal Holdings (Cosyntropin Depot)‘s full profile, request access.

Request a free trial

Slán Medicinal Holdings (Cosyntropin Depot) FAQs

  • Where is Slán Medicinal Holdings (Cosyntropin Depot) headquartered?

    Slán Medicinal Holdings (Cosyntropin Depot) is headquartered in Ireland.

  • What industry is Slán Medicinal Holdings (Cosyntropin Depot) in?

    Slán Medicinal Holdings (Cosyntropin Depot)’s primary industry is Buildings and Property.

  • Is Slán Medicinal Holdings (Cosyntropin Depot) a private or public company?

    Slán Medicinal Holdings (Cosyntropin Depot) is a Private company.

  • What is the current valuation of Slán Medicinal Holdings (Cosyntropin Depot)?

    The current valuation of Slán Medicinal Holdings (Cosyntropin Depot) is .

  • What is Slán Medicinal Holdings (Cosyntropin Depot)’s current revenue?

    The current revenue for Slán Medicinal Holdings (Cosyntropin Depot) is .

  • Who are Slán Medicinal Holdings (Cosyntropin Depot)’s investors?

    Slán Medicinal Holdings has invested in Slán Medicinal Holdings (Cosyntropin Depot).

  • When was Slán Medicinal Holdings (Cosyntropin Depot) acquired?

    Slán Medicinal Holdings (Cosyntropin Depot) was acquired on 07-Nov-2017.

  • Who acquired Slán Medicinal Holdings (Cosyntropin Depot)?

    Slán Medicinal Holdings (Cosyntropin Depot) was acquired by Assertio Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process